Nanomedicine Based Drug Delivery Systems Recent Developments and Future Prospects
This reprint entitled "Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects" contains 14 articles in total. This includes one editorial, ten research articles, and three review articles. All articles are associated with nanomedicine-based drug delivery systems...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_100903 | ||
| 005 | 20230623 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230623s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-7760-9 | ||
| 020 | |a 9783036577616 | ||
| 020 | |a 9783036577609 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7760-9 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a GP |2 bicssc | |
| 072 | 7 | |a PN |2 bicssc | |
| 100 | 1 | |a Shakeel, Faiyaz |4 edt | |
| 700 | 1 | |a Shakeel, Faiyaz |4 oth | |
| 245 | 1 | 0 | |a Nanomedicine Based Drug Delivery Systems |b Recent Developments and Future Prospects |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (242 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This reprint entitled "Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects" contains 14 articles in total. This includes one editorial, ten research articles, and three review articles. All articles are associated with nanomedicine-based drug delivery systems for the solubility, bioavailability, and therapeutic enhancement of active drug molecules. In recent years, there has been a tremendous amount of research on nanomedicine-based drug delivery systems. This reprint has brought together prominent scientists who have explored a diverse range of applications of nanomedicine-based drug delivery systems. I believe that further clinical and toxicological studies on both animal and human models are still required to explore the complete potential and commercial exploitation of nanomedicine-based drug delivery systems. The diverse and critical perspectives within this reprint provide sufficient information on the development, characterization, and evaluation of nanomedicine-based drug delivery systems. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Chemistry |2 bicssc | |
| 653 | |a bioflavonoid | ||
| 653 | |a droplet size | ||
| 653 | |a hepatoprotective effects | ||
| 653 | |a luteolin | ||
| 653 | |a SNEDDS | ||
| 653 | |a cancer | ||
| 653 | |a smart nanocarriers | ||
| 653 | |a drug targeting | ||
| 653 | |a nanoparticles | ||
| 653 | |a stimulus for drug release | ||
| 653 | |a bioavailability | ||
| 653 | |a ciprofloxacin | ||
| 653 | |a lipid-based colloidal carriers | ||
| 653 | |a ocular delivery | ||
| 653 | |a turmeric rhizome extract | ||
| 653 | |a turmeric oil | ||
| 653 | |a curcumin | ||
| 653 | |a HepG2 | ||
| 653 | |a anticancer | ||
| 653 | |a quality by design | ||
| 653 | |a quality planning | ||
| 653 | |a initial risk assessment | ||
| 653 | |a critical factors | ||
| 653 | |a thermosensitive liposomes | ||
| 653 | |a thin-film hydration method | ||
| 653 | |a dental diseases | ||
| 653 | |a essential oils | ||
| 653 | |a herb | ||
| 653 | |a natural products | ||
| 653 | |a nanotechnology | ||
| 653 | |a regulations | ||
| 653 | |a tedizolid-phosphate | ||
| 653 | |a chitosan | ||
| 653 | |a antibacterial | ||
| 653 | |a eye-irritation transcorneal-permeation | ||
| 653 | |a drug delivery | ||
| 653 | |a contraception | ||
| 653 | |a levonorgestrel | ||
| 653 | |a liposomes | ||
| 653 | |a microneedle | ||
| 653 | |a sustained-release | ||
| 653 | |a apremilast | ||
| 653 | |a psoriatic arthritis | ||
| 653 | |a pharmacokinetics studies | ||
| 653 | |a solubility | ||
| 653 | |a dissolution | ||
| 653 | |a oral bioavailability | ||
| 653 | |a functionalized fullerenes | ||
| 653 | |a fullerenols | ||
| 653 | |a antibiotics | ||
| 653 | |a gentamicin | ||
| 653 | |a antibacterial properties | ||
| 653 | |a cytotoxicity | ||
| 653 | |a skin fibroblasts | ||
| 653 | |a nanomedicine | ||
| 653 | |a tedizolid | ||
| 653 | |a antimicrobial | ||
| 653 | |a nanocrystals | ||
| 653 | |a eyeirritation | ||
| 653 | |a ocular pharmacokinetics | ||
| 653 | |a transcorneal permeation | ||
| 653 | |a quality by Design (QbD) | ||
| 653 | |a nano-pharmaceuticals | ||
| 653 | |a pharmaceutical industry | ||
| 653 | |a polyamidoamine dendrimers | ||
| 653 | |a erlotinib | ||
| 653 | |a non-small-cell lung cancer | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7371 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100903 |7 0 |z DOAB: description of the publication |